
OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Combined Sodium-Glucose-Transporters Inhibitors and Glucagon-Like-Peptide Receptor Agonist Compared With Monotherapy Improves Long-Term Survival: A Real-World Registry
David García‐Vega, Sergio Cinza‐Sanjurjo, Sonia Eirás, et al.
The American Journal of Medicine (2024) Vol. 137, Iss. 8, pp. 761-769.e1
Closed Access | Times Cited: 4
David García‐Vega, Sergio Cinza‐Sanjurjo, Sonia Eirás, et al.
The American Journal of Medicine (2024) Vol. 137, Iss. 8, pp. 761-769.e1
Closed Access | Times Cited: 4
Showing 4 citing articles:
Combining SGLT2is, GLP1-RAs and nsMRAs in Diabetes: A Scoping Review of Current and Future Perspectives
Elisabeth B. Stougaard, Viktor Rotbain Curovic, Tine W. Hansen
Diabetes Therapy (2025)
Open Access
Elisabeth B. Stougaard, Viktor Rotbain Curovic, Tine W. Hansen
Diabetes Therapy (2025)
Open Access
Combining GLP-1 Receptor Agonists and SGLT2 Inhibitors in Type 2 Diabetes Mellitus: A Scoping Review and Expert Insights for Clinical Practice Utilizing the Nominal Group Technique
Carlos Augusto Yepes, Isabel C. Cardenas-Moreno, Rodrigo Daza-Arnedo, et al.
Diabetes Therapy (2025)
Open Access
Carlos Augusto Yepes, Isabel C. Cardenas-Moreno, Rodrigo Daza-Arnedo, et al.
Diabetes Therapy (2025)
Open Access
Cardiovascular and renal effects of the combination therapy of a GLP-1 receptor agonist and an SGLT2 inhibitor in observational real-life studies
André Scheen
Diabetes & Metabolism (2024), pp. 101594-101594
Closed Access | Times Cited: 2
André Scheen
Diabetes & Metabolism (2024), pp. 101594-101594
Closed Access | Times Cited: 2
Sodium-glucose cotransporter-2 inhibitors and glucagon-like peptide 1 receptor agonists and cancer mortality. A real-world registry
David García‐Vega, Sergio Cinza‐Sanjurjo, Carlos Tilves-Bellas, et al.
Revista Española de Cardiología (English Edition) (2024)
Open Access
David García‐Vega, Sergio Cinza‐Sanjurjo, Carlos Tilves-Bellas, et al.
Revista Española de Cardiología (English Edition) (2024)
Open Access